Correlation between risk reduction of major bleeding, thrombosis, and death in non-valvular atrial fibrillation and venous thromboembolism: metaregression of antithrombotic

被引：0
|
作者：
Kilo, R. [1 ,2 ]
Lega, J. [1 ,3 ,4 ]
Provencher, S. [5 ]
Bertoletti, L. [4 ,6 ,7 ,8 ]
机构：
[1] Univ Claude Bernard Lyon 1, Lab Biometrie & Biol Evolut, Equipe Evaluat & Modelisat Effets Therapeut, Univ Lyon 1,CNRS,UMR 5558, Lyon, France
[2] Hosp Civils Lyon, Pole Sante Publ, Lyon, France
[3] Hosp Civils Lyon, Hop Lyon Sud, Serv Med Interne & Vasc, Lyon, France
[4] Hosp Civils Lyon, Grp Etud Multidisciplinaires Malad Thrombot GEMMA, Lyon, France
[5] Univ Laval, Inst Univ Cardiol & Pneumol, Pulm Hypertens Res Grp, Dept Med,Quebec Res Ctr, Quebec City, PQ, Canada
[6] CHU St Etienne, Serv Med Vasc & Therapeut, F-42055 St Etienne, France
[7] Univ St Etienne, Equipe Dysfonct Vasc & Hemostase, INSERM, UMR1059, F-42055 St Etienne, France
[8] CHU St Etienne, INSERM, CIC 1408, F-42055 St Etienne, France
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 78卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
302
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] Venous Thromboembolism and Atherosclerotic Events in Patients With Non-Valvular Atrial Fibrillation
    Thomopoulos, Costas
    [J]. ANGIOLOGY, 2022, 73 (05) : 393 - 394
  • [2] Temporal trends in thromboembolism and bleeding in patients with non-valvular atrial fibrillation between 1996 and 2011
    Hansen, P. W.
    Gislason, G.
    Torp-Pedersen, C.
    Andersson, C.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1084 - 1084
  • [3] Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review
    Pallazola, Vincent A.
    Kapoor, Rishi K.
    Kapoor, Karan
    McEvoy, John W.
    Blumenthal, Roger S.
    Gluckman, Ty J.
    [J]. VASCULAR MEDICINE, 2019, 24 (02) : 141 - 152
  • [4] DISTRIBUTION OF THROMBOEMBOLISM IN VALVULAR COMPARED TO NON-VALVULAR ATRIAL FIBRILLATION
    Ketha, Siva S.
    McBane, Robert
    Grill, Diane
    Mehta, Ramila
    Wysokinski, Waldemar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A368 - A368
  • [5] Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation
    Blustin, Jodi M.
    McBane, Robert D.
    Ketha, Siva S.
    Wysokinski, Waldemar E.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (10) : 1129 - 1132
  • [6] Antithrombotic strategies for the management of non-valvular atrial fibrillation
    Nixdorff, U
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (02) : 191 - 198
  • [7] Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism
    Lin, Yu-Sheng
    Tsai, Hsin-Yu
    Lin, Chia-Ying
    Wu, Victor Chien-Chia
    Chen, Tien-Hsing
    Yang, Teng-Yao
    Aboyans, Victor
    Chen, Mien-Cheng
    [J]. GLOBAL HEART, 2021, 16 (01)
  • [8] Combination antithrombotic therapy and bleeding risk: comparing atrial fibrillation and venous thromboembolism
    Song, Melinda
    Haymart, Brian
    Kong, Xiaowen
    Ali, Mona
    Kozlowski, Jay
    Krol, Gregory
    Kaatz, Scott
    Froehlich, James
    Barnes, Geoff
    [J]. VASCULAR MEDICINE, 2021, 26 (05) : NP10 - NP10
  • [9] A SINGLE CENTRE RETROSPECTIVE ANALYSIS OF THE INCIDENCE OF MAJOR BLEEDING IN OVER 1000 PATIENTS COMMENCED ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION AND VENOUS THROMBOEMBOLISM
    Jenkins, S.
    Mushkbar, M.
    Koghar, R.
    [J]. HAEMATOLOGICA, 2014, 99 : 480 - 481
  • [10] Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Alberts, Mark J.
    Eikelboom, John W.
    Hankey, Graeme J.
    [J]. LANCET NEUROLOGY, 2012, 11 (12): : 1066 - 1081
12345